Volume 27, Number 11—November 2021
Research
Hepatitis A Virus Incidence Rates and Biomarker Dynamics for Plasma Donors, United States
Figure 1

Figure 1. Incidence rates for hepatitis A virus (HAV) in source plasma donors, United States, 2016‒2020. Shown are monthly HAV incidence rates based on routine viral marker testing. Incidence rates correspond to monthly number of previously HAV RNA-negative donors with a first positive HAV nucleic acid testing result per 100,000 donors.
Page created: August 02, 2021
Page updated: October 19, 2021
Page reviewed: October 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.